Patterns of benzodiazepine use in a Canadian population sample

Epidemiologia e Psichiatria Sociale

Volumn 18, Issue 3, 2009, Pages 248-254

  Esposito, Eleonora ^a,b   Barbui, Corrado ^b   Patten, Scott B ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

Benzodiazepines; Cross sectional study; Population study; Psychiatric disorders

Indexed keywords

BENZODIAZEPINE DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANADA; DRUG UTILIZATION; FEMALE; HUMAN; MALE; MIDDLE AGED; STATISTICS;

ADOLESCENT; ADULT; AGED; ALBERTA; BENZODIAZEPINES; DRUG UTILIZATION; FEMALE; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 75549083765     PISSN: 1121189X     EISSN: None     Source Type: Journal    
DOI: 10.1017/s1121189x00000531     Document Type: Article

References (32)

1. American Psychiatriec Association Task force on Benzodiazepine Dependency (1990). Benzodiazepine Dependence, Toxicity and Abuse. American Psychiatric Association, Washington.
2. Brunette M.F., Noordsy D.L., Xie H. & Drake R.E. (2003). Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders. Psychiatric Services 54, 1395-1401.
3. Clark R.E., Xie H. & Brunette M.F. (2004). Benzodiazepine prescription practices and substance abuse in persons with severe mental illness. Journal of Clinical Psychiatry 65, 151-155.
4. Department of Health and Children (2002). Report of the Benzodiazepine Committee. Stationary Office: Dublin.
5. ESEMeD Investigators (2004). Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatrica Scandinava 109, Suppl, 420, 55-64.
6. Esposito E., Wang J.L., Williams J.V. & Patten S.B. (2007). Mood and anxiety disorders, the association with presenteeism in employed members of a general population sample. Epidemiologia e Psichiatria Sociale 16, 231-237.
7. Gray S.L., LaCroix A.Z., Blough D., Wagner E.H., Koepsell T.D. & Buchner D. (2002). Is the use of benzodiazepines associated with incident disability? Journal of American Geriatric Society 50, 1012-1018.
8. Haw C. & Stubbs J. (2007). Benzodiazepines-a necessary evil? A survey of prescribing at a specialist UK psychiatric hospital. Journal of Psychopharmacology 21, 645-649.
9. Hemmelgarn B., Suissa S., Huang A., Boivin J.F. & Pinard G. (1997). Benzodiazepine use and the risk of motor vehicle crash in the elderly. Journal of the American Medical Association 278, 27-31.
10. Hogan D.B., Maxwell C.J., Fung T.S. & Ebly E.M. (2003). Prevalence and potential consequences of benzodiazepine use in senior citizens: results from the Canadian Study of Health and Aging. Canadian Journal of Clinical Pharmacology 10, 72-77.
11. Kassam A. & Patten S.B. (2006). Hypnotic use in a population-based sample of over thirty-five thousand interviewed Canadians. Population Health Metrix 4, 15.
12. Koski A., Ojanpera I. & Vuori E. (2002). Alcohol and benzodiazepines in fatal poisonings. Alcoholism. Clinical and Experimental Research 26, 956-959.
13. Lagnaoui R., Depont F., Fourrier A., Abouelfath A., Begaud B., Verdoux H. & Moore N. (2004). Patterns and correlates of benzodiazepine use in the French general population. European Journal of Clinical Pharmacology 60, 523-529.
14. Lecubier Y., Sheehan D.V., Weiller E., Amorim P., Bonora I., Harnett Sheehan K., Janavs J. & Dunbar G.C. (1997). The MINI International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. European Psychiatry 12, 224-231. (Pubitemid 27298915)
15. Magrini N., Vaccheri A., Parma E., D'Alessandro R., Bottoni A., Occhionero M. & Montanaro N. (1996). Use of benzodiazepines in the Italian general population: prevalence, pattern of use and risk factors for use. European Journal of Clinical Pharmacology 50, 19-25.
16. Mol A.J., Gorgels W.J., Oude Voshaar R.C, Breteler M.H., van Balkom A.J., van de Lisdonk E.H., Kan C.C. & Zitman F.G. (2005). Associations of benzodiazepine craving with other clinical variables in a population of general practice patients. Comprehensive Psychiatry 46, 353-360.
17. Mol A.J., Oude Voshaar R.C., Gorgels W.J., Breteler M.H., van Balkom A.J., van de Lisdonk E.H., Kan C.C., Mulder J. & Zitman F.G. (2006). The absence of benzodiazepine craving in a general practice benzodiazepine discontinuation trial. Addictive Behaviors 31, 211-222.
18. Narrow W.E., Rae D.S., Robins L.N. & Regier D.A. (2002). Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys' estimates. Archives of General Psychiatry 59, 115-123.
19. Neutel C.I. (2005). The epidemiology of long-term benzodiazepine use. International Review of Psychiatry 17, 189-197.
20. Neutel C.I., Walop W. & Patten S.B. (2003). Can continuing benzodiazepine use be predicted? Canadian Journal of Clinical Pharmacology 10, 202-206.
21. Nose M & Barbui C. (2008). A simple approach to manage dosages in drug-epidemiology research. Epidemiologia e Psichiatria Sociale 17, 186-187.
22. O'Connor K., Belanger L., Marchand A., Dupuis G., Elie R. & Boyer R. (1999). Psychological distress and adaptational problems associated with discontinuation of benzodiazepines. Addictive Behaviors 24, 537-541.
23. Pelissolo A., Andre C., Chignon J.M., Dutoit D., Martin P., RichardBerthe C. & Tignol J. (2002). Anxiety disorders in private practice psychiatric out-patients: prevalence, comorbidity and burden (DELTA study). Encephale 28, 510-519.
24. Pelissolo A., Maniere F., Boutges B., Allouche M., Richard-Berthe C. & Corruble E. (2007). Anxiety and depressive disorders in 4,425 long term benzodiazepine users in general practice. Encephale 33, 32-38.
25. Petitjean S., Ladewig D., Meier C.R., Amrein R. & Wiesbeck G.A. (2007). Benzodiazepine prescribing to the Swiss adult population: results from a national survey of community pharmacies. International Clinical Psychopharmacology 22, 292-298.
26. Rawson N.S. & D'Arey C. (1991). Sedative-hypnotic drug use in Canada. Health Reports 3, 33-57.
27. Ray W.A., Griffin M.R. & Downey W. (1989). Benzodiazepines of long and short elimination half-life and the risk of hip fracture. Journal of the American Medical Association 262, 3303-3307.
28. Royal Australian College of General Practitioners (2000). Benzodiazepine Guidelines. Retrieved May 15, 2009, from http://www.racgp.org.au/guidelines/ benzodiazepines
29. Sheehan, D. V., Lecubier, Y., Sheehan, K. H., Janavs, J., Weiller, E., Keskiner, A., Schinka, J., Knapp, E., Sheehan, M. F. & Dunbar, G. C. The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its validity. European Journal of Psychiatry 12, 232-241.
30. Vicens C., Fiol F., Llobera J., Campoamor F., Mateu C., Alegret S. & Socias I. (2006). Withdrawal from long-term benzodiazepine use: randomised trial in family practice. British Journal of General. Practice 56, 958-963.
31. Wagner A.K., Zhang F., Soumerai S.B., Walker A.M., Gurwitz J.H., Glynn R.J. & Ross-Degnan D. (2004). Benzodiazepine use and hip fractures in the elderly: who is at greatest risk? Archives of Internal Medicine 164, 1567-1572.
32. World Health Organization (2002). The ICD-10 Classification of Mental and Behavioural Disorders. Clinical Escrtptions and Diagnostic Guidelines. World Health Organization, Geneva.